PT941738E - Conjugados antigenicos de lipopolissacaridos conservados de bacterias gram negativas - Google Patents

Conjugados antigenicos de lipopolissacaridos conservados de bacterias gram negativas

Info

Publication number
PT941738E
PT941738E PT99301747T PT99301747T PT941738E PT 941738 E PT941738 E PT 941738E PT 99301747 T PT99301747 T PT 99301747T PT 99301747 T PT99301747 T PT 99301747T PT 941738 E PT941738 E PT 941738E
Authority
PT
Portugal
Prior art keywords
lipopolissacarides
preserved
lipopolysaccharide
antigenic conjugates
gram bacteria
Prior art date
Application number
PT99301747T
Other languages
English (en)
Inventor
Bradford W Gibson
Rasappa G Arumugham
Nevin Maria Fortuna
Michael A Apicella
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21894823&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT941738(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of PT941738E publication Critical patent/PT941738E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT99301747T 1998-03-10 1999-03-09 Conjugados antigenicos de lipopolissacaridos conservados de bacterias gram negativas PT941738E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3752998A 1998-03-10 1998-03-10

Publications (1)

Publication Number Publication Date
PT941738E true PT941738E (pt) 2005-09-30

Family

ID=21894823

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99301747T PT941738E (pt) 1998-03-10 1999-03-09 Conjugados antigenicos de lipopolissacaridos conservados de bacterias gram negativas

Country Status (12)

Country Link
EP (1) EP0941738B1 (pt)
JP (1) JPH11322793A (pt)
KR (1) KR100628664B1 (pt)
AT (1) ATE295181T1 (pt)
AU (2) AU766184B2 (pt)
BR (1) BR9902008A (pt)
CA (1) CA2264970A1 (pt)
DE (1) DE69925187T2 (pt)
DK (1) DK0941738T3 (pt)
ES (1) ES2241240T3 (pt)
PT (1) PT941738E (pt)
SI (1) SI0941738T1 (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE435028T1 (de) * 1999-09-30 2009-07-15 Isis Innovation Impfstoff gegen neisseria infektion
US7749511B2 (en) 2000-04-18 2010-07-06 Endobiologics, Incorporated Anti-sepsis conjugate vaccine
JP2004515450A (ja) 2000-04-18 2004-05-27 エンドバイオロジックス， インコーポレイテッド 敗血症処置のためのリポ多糖結合体ワクチン
JP2004506086A (ja) 2000-08-25 2004-02-26 アベンティス、パストゥール、リミテッド インフルエンザ菌感染症の予防用ワクチンとしてのインフルエンザ菌リポ多糖内部コアオリゴ糖エピトープ
WO2002020059A2 (en) * 2000-09-01 2002-03-14 The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services Vibrio cholerae o139 conjugate vaccines
EP1374892A1 (en) * 2002-06-28 2004-01-02 Braun, Jan Matthias, Dr. Medicament for the treatment of diseases due to infection by Neisseria Meningitidis
KR101239242B1 (ko) 2002-08-02 2013-03-11 글락소스미스클라인 바이오로지칼즈 에스.에이. 항원 조합물을 포함하는 나이세리아 백신 조성물
WO2004043405A2 (en) 2002-11-12 2004-05-27 The Brigham And Women's Hospital, Inc. Polysaccharide vaccine for staphylococcal infections
MY144231A (en) 2003-12-17 2011-08-15 Wyeth Corp Aß IMMUNOGENIC PEPTIDE CARRIER CONJUGATES AND METHODS OF PRODUCING SAME
EA012984B1 (ru) * 2003-12-17 2010-02-26 Вайет Конъюгаты иммуногенных пептидных носителей и способы их получения
ES2493440T3 (es) 2004-12-17 2014-09-11 De Staat Der Nederlanden, Vert. Door De Minister Van Vws, Ministerie Van Volksgezondheid, Welzijn En Sport Desacilación de LPS en bacterias Gram negativas
US8329184B2 (en) 2005-06-27 2012-12-11 Glaxosmithkline Biologicals S.A. Process for manufacturing vaccines
TW200806315A (en) * 2006-04-26 2008-02-01 Wyeth Corp Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
DE602007003596D1 (de) 2006-06-12 2010-01-14 Glaxosmithkline Biolog Sa Impfstoff
KR20110031393A (ko) 2008-07-21 2011-03-25 더 브리검 앤드 우먼즈 하스피털, 인크. 합성 베타-1,6 글루코사민 올리고당에 관한 방법 및 조성물
WO2010130896A2 (fr) 2009-05-14 2010-11-18 Sanofi Pasteur Procédé pour adjuver le lipopolysaccharide (lps) des bactéries à gram-négatif
WO2010130898A2 (fr) 2009-05-14 2010-11-18 Sanofi Pasteur Vaccin meningocoque a base de lipooligosaccharide (los) provenant de souches modifiees de neisseria meningitidis d'immunotype l6
WO2010134225A1 (ja) * 2009-05-20 2010-11-25 国立大学法人鳥取大学 部分糖鎖エピトープを用いた、病原性ナイセリア属細菌感染の検出方法およびそれら細菌に対するワクチン
CA2792683A1 (en) 2010-03-10 2011-09-15 Glaxosmithkline Biologicals S.A. Neisserial fhbp vaccine composition
AU2011262346B2 (en) 2010-06-04 2014-12-11 Wyeth Llc Streptococcus pneumoniae vaccine formulations
PL404229A1 (pl) 2013-06-06 2014-12-08 Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Odpowiedzialnością Wyizolowany immunogenny antygen bakteryjny i jego zastosowanie w profilaktyce i leczeniu zakażeń wywołanych przez Gram-ujemne bakterie
CN103308686B (zh) * 2013-06-28 2016-04-06 武汉云克隆科技股份有限公司 脂多糖酶联免疫吸附测定试剂盒的制备方法
KR101509456B1 (ko) * 2013-10-04 2015-04-14 아이진 주식회사 리포폴리사카라이드 유사체 및 이를 포함하는 면역보조 조성물
CN104352762A (zh) * 2014-12-11 2015-02-18 谭清平 一种用于治疗脓毒症的中药及其制备方法
MX2019002489A (es) 2016-09-02 2019-10-21 Sanofi Pasteur Inc Vacuna contra neisseria meningitidis.
US20230137821A1 (en) * 2016-11-25 2023-05-04 Glaxosmithkline Biologicals, S.A. Immunogenic conjugates and use thereof
CN112125832B (zh) * 2020-08-12 2022-09-20 北京大学 刺突蛋白受体结合结构域纳米凝胶及其制备方法与应用
JP2024510334A (ja) * 2021-03-15 2024-03-06 グリフィス・ユニバーシティ 病原体部分及びその用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6887483B2 (en) * 1995-12-01 2005-05-03 University Of Iowa Research Foundation Non-toxic mutants of pathogenic gram-negative bacteria

Also Published As

Publication number Publication date
JPH11322793A (ja) 1999-11-24
AU766184B2 (en) 2003-10-09
ATE295181T1 (de) 2005-05-15
AU2004200060B2 (en) 2005-10-13
CA2264970A1 (en) 1999-09-10
DK0941738T3 (da) 2005-08-08
DE69925187T2 (de) 2006-03-09
DE69925187D1 (de) 2005-06-16
KR19990077705A (ko) 1999-10-25
BR9902008A (pt) 2000-05-09
AU1954099A (en) 1999-09-23
SI0941738T1 (en) 2005-10-31
ES2241240T3 (es) 2005-10-16
KR100628664B1 (ko) 2006-09-27
AU2004200060A1 (en) 2004-01-29
EP0941738B1 (en) 2005-05-11
EP0941738A1 (en) 1999-09-15

Similar Documents

Publication Publication Date Title
PT941738E (pt) Conjugados antigenicos de lipopolissacaridos conservados de bacterias gram negativas
NO902909D0 (no) T-celle-epitop som baerermolekyl for konjugat-vaksiner.
WO1998058668A3 (en) Bordetella pertussis antigens as carriers in vaccinating conjugates and oral vaccines comprising bordetella pertussis fimbriae
NO2006005I1 (no) Difteri-,tetanus-, acellulære kikhoste- og polioantigener
ES542919A0 (es) Un procedimiento para la preparacion de conjugados estables y covalentemente copulados de polisacarido-proteina.
DK1028749T3 (da) Enterococcus-antigener og -vacciner
AU7545298A (en) Culture medium with yeast or soy bean extract as aminoacid source and no proteincomplexes of animal origin
IE853227L (en) Modified polysaccharides and their conjugates with¹immunogenic proteins
FI862370A (fi) Monoklonaalisia vasta-aineita syklosporiineille
GB9928196D0 (en) Combinations of B, C and other antigens
WO2000071154A3 (de) Stabilitäts-, biokompatibilitäts-optimiertes adjuvans (sba) zur erhöhung der humoralen und zellulären immunantwort
EP0694309A3 (en) Vaccine, antigens and antibodies containing compound for inhibiting and preventing induced staphylococcus infection
AU576088B2 (en) Histamine derivatives, immunogen conjugates and antibodies raised thereto
EP0345559A3 (en) Hiv-2 variants
GB9602878D0 (en) Pseudomonas exotoxin as immunogenic carrier in synthetic conjugate vaccines
ZA968988B (en) Pseudomonas exotoxin as immunogenic carrier in synthetic conjugate vaccines